Salts pharmaceutical forms

The different salts, esters, ethers, isomers, mixtures of isomers, complexes or derivatives of an active substance shall be considered to be the same active substance, unless they differ significantly in properties with regard to safety and/or efficacy, in which case additional safety and efficacy data are required. The same qualitative and quantitative composition only applies to the active ingredients. Differences in excipients will be accepted unless there is concern that they may substantially alter the safety or efficacy. The same pharmaceutical form must take into account both the form in which it is presented and the form in which it is administered. Various immediate-release oral forms, which would include tablets, capsules, oral solutions and suspensions, shall be considered the same pharmaceutical form for this purpose. 

US patent 6,833,379, Crystal modification of torasemide [119], This invention relates to the characterization of a new crystal modification III of torasemide, to a process for its preparation by the use of controlled acidifying of alkaline solutions of torasemide with inorganic or organic acids with or without addition of a crystal seed, to its use as a raw material for the preparation of the crystal modification I of torasemide and of pharmaceutically acceptable salts of torasemide, as well as to pharmaceutical forms containing this new torasemide crystal modification. 

Salts Compounds formed by the union of acids and bases, by the action of alkalies upon metals, or by the direct union of elements. The term is often incorporated in the common name of salts used as pharmaceuticals bitter salts, epsom salt, or Seidlitz salt (magnesium sulfate), preparing salt (sodium stannate), Preston s salts (ammonium chloride), Rochelle salt or Seignette s salt (potassium and ammonium tartrate), salt of Mars (ferrous sulfate), salt of Saturn (lead acetate), salt of tartar (potassium carbonate), salt of tin (stannous chloride), salt of wisdom (mercury bichloride and ammonium chloride), sore-throat salt (fused potassium nitrate), vinegar salts (calcium acetate), and vomiting salt (zinc sulfate). The term is also applied to some acids, such as salt of lemon or sour salt (citric acid), salt of sorrel (oxalic acid), and spirit of salt (muriatic acid). ... 

Solutions of elsinan gives high viscosity and pseudoplasticity. The viscosity exhibits excellent pH stability, and compatibility with the presence of salts. Elsinan forms strong and resilient films that are imprevious to oxygen. These properties and partial digestibility by a-amylases may propose wide utilization of elsinan in food, pharmaceutical and other industries. 

Application of Mechanochemistry in the Synthesis and Discovery of New Pharmaceutical Forms Co-crystals, Salts and Coordination Compounds... 

As a therapeutic agent, ch oline is adininistered orally in the form of symps or elixers containing the chloride, citrates or bitartrate, or in the form of compressed tablets or capsules of the dihydrogen citrate. Choline is also given in small doses as a nutritional supplement in combination with a variety of other materials. In dry pharmaceutical-dosage forms, the dihydrogen citrate is usually preferred because of its lower tendency to absorb atmospheric moisture. Both salts have been used parenteraHy. 

Carmine [1390-65-4] is the trade name for the aluminum lake of the red anthraquinone dye carminic acid obtained from the cochineal bug. The dye is obtained from the powdery form of cochineal by extraction with hot water, the extracts treated with aluminum salts, and the dye precipitated from the solution by the addition of ethanol. This water-soluble bright red dye is used for coloring shrimp, pork sausages, pharmaceuticals, and cosmetics. It is the only animal-derived dye approved as a colorant for foods and other products. 

HaO). Quinine salicylate, 2[B. CgH4(OH)(COOH)]. HaO, forms colourless needles, m.p. 187° (dec.), which slowly become pink in air. It is soluble in water (1 in 77 at 25°), alcohol (1 in 11 at 25°), or chloroform (1 in 37 at 25°). The foregoing are the most important quinine salts used in medicine, but many other salts have been used, e.g., the tannate, formate, valerate, ethylcarbonate, lactate, cacodylate, etc., as well as double salts such as quinine bismuth iodide. Descriptions of many of these salts will be found in the British Pharmaceutical Codex for 1934. 

The first clinical trials were performed in the 1970 s using a sodium salt derivative with an open E-ting (Fig. 1). However, the clinical efficacy was limited and severe bladder toxicity led to the termination of the clinical trials. The poor efficacy of the camptothecin sodium salt in those clinical trials was probably due to the fact that the open E-ring form of camptothecin (carboxylate derivative) is inactive as a Topi inhibitor. Following the identification of Topi as a target of camptothecin, water-soluble derivatives were produced by the pharmaceutical industry. Two of these water-soluble derivatives have been approved by the FDA for cancer treatment in the early 2000s topotecan and irinotecan. 

---